DPP4 and cardiovascular disorder: In addition, we surveyed human serum samples from the Baltimore Longitudinal Study of Aging (BLSA) (27) from people aged 50 to 65 with low and high Framingham risk scores (FRS) (28), which estimate the risk of cardiovascular disease, for circulating levels of DPP4.